JP2024502620A5 - - Google Patents

Info

Publication number
JP2024502620A5
JP2024502620A5 JP2023541690A JP2023541690A JP2024502620A5 JP 2024502620 A5 JP2024502620 A5 JP 2024502620A5 JP 2023541690 A JP2023541690 A JP 2023541690A JP 2023541690 A JP2023541690 A JP 2023541690A JP 2024502620 A5 JP2024502620 A5 JP 2024502620A5
Authority
JP
Japan
Prior art keywords
ribozyme
rna
sequence
activated
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541690A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502620A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/012004 external-priority patent/WO2022150773A2/en
Publication of JP2024502620A publication Critical patent/JP2024502620A/ja
Publication of JP2024502620A5 publication Critical patent/JP2024502620A5/ja
Pending legal-status Critical Current

Links

JP2023541690A 2021-01-11 2022-01-11 リボザイムで活性化されたrna構築物及びその使用 Pending JP2024502620A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163136201P 2021-01-11 2021-01-11
US63/136,201 2021-01-11
PCT/US2022/012004 WO2022150773A2 (en) 2021-01-11 2022-01-11 Ribozyme-activated rna constructs and uses thereof

Publications (2)

Publication Number Publication Date
JP2024502620A JP2024502620A (ja) 2024-01-22
JP2024502620A5 true JP2024502620A5 (enExample) 2025-01-21

Family

ID=82358774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541690A Pending JP2024502620A (ja) 2021-01-11 2022-01-11 リボザイムで活性化されたrna構築物及びその使用

Country Status (4)

Country Link
US (1) US20260115275A1 (enExample)
EP (1) EP4247946A4 (enExample)
JP (1) JP2024502620A (enExample)
WO (1) WO2022150773A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115806984B (zh) * 2022-10-18 2023-10-10 昆明理工大学 环状rna及载体和载体的应用
CN116200442A (zh) * 2023-03-17 2023-06-02 清华大学 一种基于毕赤酵母的无细胞合成体系及应用
CN122206801A (zh) * 2023-10-18 2026-06-12 泰思特治疗公司 反式剪接核酸分子及其使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2476707B1 (en) * 2003-11-14 2017-05-24 Children's Medical Center Corporation Self-cleaving ribozymes and uses thereof
JP5913122B2 (ja) * 2010-11-08 2016-04-27 Jcrファーマ株式会社 新規発現ベクター
MY198399A (en) * 2016-02-02 2023-08-28 Meiragtx Uk Ii Ltd Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes
WO2018237372A1 (en) * 2017-06-23 2018-12-27 Cornell University RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT
SG11202111264TA (en) * 2019-04-12 2021-11-29 Agency Science Tech & Res A ribozyme comprising a target-binding domain
US20220213469A1 (en) * 2019-04-30 2022-07-07 The Broad Institute, Inc. Methods and compositions for barcoding nucleic acid libraries and cell populations
EP3986458A1 (en) * 2019-06-20 2022-04-27 Janssen Sciences Ireland Unlimited Company Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof
EP4100533A1 (en) * 2020-02-07 2022-12-14 University of Rochester Ribozyme-mediated rna assembly and expression
EP4158017A1 (en) * 2020-05-26 2023-04-05 Shape Therapeutics Inc. Engineered circular polynucleotides
KR20230028375A (ko) * 2020-06-25 2023-02-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 원형 rna 번역을 구동하는 유전 요소와 이를 사용하는 방법
AR125216A1 (es) * 2021-03-26 2023-06-28 Flagship Pioneering Innovations Vii Llc Producción de polirribonucleótidos circulares en un sistema eucariota

Similar Documents

Publication Publication Date Title
JP2008545406A5 (enExample)
JP7083595B2 (ja) 高反復モチーフを備えたdna配列を効率的かつ特異的に標的とするレアカットエンドヌクレアーゼの設計
JP2024073596A5 (enExample)
JP2023126487A5 (enExample)
JP2017205126A5 (enExample)
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2018531023A5 (enExample)
JP2015503535A5 (enExample)
US20250223592A1 (en) Compositions and methods for circular rna affinity purification
JP2012520085A5 (enExample)
JP2007500017A5 (enExample)
JP2023524577A5 (enExample)
JP2023528300A5 (enExample)
JP2004501646A5 (enExample)
JP2020518265A5 (enExample)
JP2023521662A5 (enExample)
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
JP2025500373A5 (enExample)
JP2023549357A5 (enExample)
JP2024534639A5 (enExample)
WO2023035372A1 (zh) 一种有限自我复制mRNA分子系统、制备方法及应用
Wang et al. Exploring the potential and advancements of circular RNA therapeutics
CN120813695A (zh) 用于生成环状rna的组合物和方法
JP2024545253A5 (enExample)
WO2025102994A1 (zh) 基于i型内含子的rna体外环化与滚环翻译的方法及其应用